Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 18 Apr 2006, 7:30 Wellco - Acquisition Of Nutribrands
WLL
 WLL                                                                             
Wellco - Acquisition Of Nutribrands                                             
Wellco Health Limited                                                           
(formerly Nungu Trading 279 (Pty) Ltd)                                          
(Incorporated in the Republic of South Africa)                                  
(Registration number 2005/005805/06)                                            
Share code: WLL    ISIN: ZAE000071841                                           
("Wellco" or "the company")                                                     
ACQUISITION OF NUTRIBRANDS                                                      
1.   INTRODUCTION                                                               
     River Group is authorised to announce that, following the renewed          
     cautionary announcement dated 31 March 2006, Wellco Health Limited entered 
into a contract with Nutribrands (Pty) Ltd on 3 April 2006 and have        
     acquired with effective date 1 April 2006 all intellectual property and    
     incidental assets of Nutribrands (Pty) Ltd ("Nutribrands") on a going      
     concern basis.                                                             
2.   ACQUISITION AND PURCHASE CONSIDERATION                                     
     Wellco has entered into an agreement to purchase 51% of Nutribrands for    
     R3,67 million with effect from 1 April 2006 and will hold an option to     
     purchase the 49% balance within 90 days after 1 April 2008 based on certain
profit warranties.                                                         
3.   BACKGROUND AND RATIONALE                                                   
     Nutribrands develops, manufactures and distributes two ranges of products; 
     Nutrimax sports nutrition and the Skin Nutrition range of cosmeceuticals.  
The products within both brands consist of state-of-the-art proprietary    
     formulations and are considered to be leaders in their category, from a    
     quality and technology perspective.                                        
     The sports nutrition category, within the complementary health sector,     
accounts for 9% (R220m) of the total R2.3bn market. There has been         
     significant growth in this category and Wellco believes that the Nutrimax  
     brand is ideally placed to experience strong growth with the marketing and 
     operational support to be supplied by Wellco Brands. In addition, Nutrimax 
will be integrated into the foreign export structures and private label    
     business. This will increase distribution and revenue opportunities.       
     The Nutrimax sports nutrition range of supplements is sold through the     
     Clicks chain, Dis-Chem, independent pharmacies, health shops, gyms, sports 
shops, personal trainers and juice bars, while the Skin Nutrition          
     cosmeceutical range is sold exclusively through Edgars department stores   
     and to independent beauty salons.                                          
     The sports nutrition range offers products to those persons seeking        
improved performance, maximizing weight loss, enhanced energy levels, and  
     better nutrition. Cosmeceuticals represent those cosmetic products that    
     have therapeutic effects on the skin. Skin Nutrition products are          
     specifically designed to reverse the signs of ageing by penetrating deep   
below the surface of the skin with advanced anti-aging ingredients created 
     to prevent cellular inflammation while promoting cellular renewal.         
     Cosmeceuticals represent the fastest growing sector in the cosmetic        
     industry worldwide.                                                        
4.   TRANSACTION STRUCTURE AND FINANCIAL EFFECTS OF THE TRANSACTIONS            
     The purchase consideration will be settled in cash by way of a vendor      
     placement by Wellco within the next thirty days.                           
     The table below sets out the unaudited reviewed pro forma financial effects
of the transaction based on Wellco"s published reviewed interim results for
     the period ended 31 August 2005 and the Prospectus dated 15 September 2005.
     The unaudited reviewed pro forma financial effects are presented for       
     illustrative purposes only and because of their nature may not give a fair 
reflection of Wellco"s results, financial position and changes in equity   
     after the transaction. It has been assumed for purposes of the pro forma   
     financial effects that the transactions took place with effect from 1 March
     2005 for income statement purposes and 31 August 2005 for balance sheet    
purposes. The directors of Wellco are responsible for the preparation of   
     the unaudited reviewed pro forma financial effects.                        
                                 Actual       Pro forma      Percentage         
                                 "before"     "after" (2)    change             
(1)                                            
     Number of shares in issue   56 827 842   65 013 026     14,40%             
     Earnings  per share         (0,68)       (1,02)         (50%)              
     (cents) (3)                                                                
Headline earnings per       (0,55)       (0,91)         (65%)              
     share (cents) (3)                                                          
     Net asset value per share   51,81        50,95          (1.66%)            
     (cents) (4)                                                                
Net tangible asset value    9,22         9,28           (0,65%)            
     per share (cents) (4)                                                      
     Notes:                                                                     
     1.   Extracted from the unaudited interim financial statements and pre-    
listing statement of Wellco for the six months ended 31 August 2005.  
     2.   Unaudited pro forma financial effects of the issue of 8,185,184 shares
          at 45 cps and the losses for 6 months of Nutrimax.                    
     3.   In relation to the pro forma earnings and headline earnings per share,
it has been assumed that the proposed transactions was effective on 1 
          March 2005; and                                                       
     4.   In relation to the net asset value and net tangible asset value per   
          share, it was assumed that the transaction was effective on 31 August 
2005.                                                                 
5.   CONDITIONS PRECEDENT                                                       
All conditions precedent have been met.                                         
Pretoria                                                                        
13 April 2006                                                                   
Corporate and Designated Advisor                                                
River Group                                                                     
Warning: The listing of ordinary shares in the company is on the AltX.          
Shareholders are advised of the risks of investing in a company listed on the   
AltX. Shareholders are advised that the JSE does not guarantee the viability or 
the success of a company listed on the AltX. In terms of the JSE Listings       
Requirements a Designated Advisor has to be retained by the company. The        
Designated Advisor is required to, inter alia, attend all board meetings held by
the company to ensure that all JSE Listings Requirements and applicable         
regulations are complied with, approve the financial director of the company and
guide the company in a competent, professional and impartial manner. If the     
company fails to retain a Designated Advisor it must make arrangement to appoint
a new Designated Advisor within 10 business days, failing which the company     
faces suspension of trading of its securities. If a Designated Advisor is not   
appointed within 30 days of its suspension the company faces the termination of 
its listing without an offer to minority shareholders.                          
Date: 18/04/2006 07:30:05 AM Produced by the JSE SENS Department                
                                                                                
                                                                                
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: